BCL6 and post-transplant lymphoproliferative disease: MYC translocations and mutations in TP53 and BCL6 have been found in some PTLD cases,77 but such somatic mutations in EBV-positive PTLD patients are less frequent than in EBV-negative PTLD cases.76